Abstract:Background/Aims: Hepatocellular carcinoma (HCC) remains a difficult problem that significantly affects the survival of the afflicted patients. Accumulating evidence has demonstrated the functions of long non-coding RNA (lncRNA) in HCC. In the present study, we aimed to explore the potential roles of PVT1 in the tumorigenesis and progression of HCC. Methods: In this study, quantitative reverse transcription-polymerase chain reaction (RT-qPCR) was applied to detect the differences between PVT1 expression in HCC tissues and cell lines. Then, the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases were searched to confirm the relationship between PVT1 expression and HCC. Moreover, a meta-analysis comprising TCGA, GEO, and RT-qPCR was applied to estimate the expression of PVT1 in HCC. Then, cell proliferation was evaluated in vitro. A chicken chorioallantoic membrane (CAM) model of HCC was constructed to measure the effect on tumorigenicity in vivo. To further explore the sponge microRNA (miRNA) of PVT1 in HCC, we used TCGA, GEO, a gene microarray, and target prediction algorithms. TCGA and GEO and the gene microarray were used to select the differentially expressed miRNAs, and the different target prediction algorithms were applied to predict the target miRNAs of PVT1. Results: We found that PVT1 was markedly overexpressed in HCC tissue than in normal liver tissues based on both RT-qPCR and data from TCGA, and the overexpression of PVT1 was closely related to the gender and race of the patient as well as to higher HCC tumor grades. Also, a meta-analysis of 840 cases from multiple sources (TCGA, GEO and the results of our in-house RT-qPCR) showed that PVT1 gained moderate value in discriminating HCC patients from normal controls, confirming the results of RT-qPCR. Additionally, the upregulation of PVT1 could promote HCC cell proliferation in vitro and vivo. Based on the competing endogenous RNA (ceRNA) theory, the PVT1/miR-424-5p/INCENP axis was finally selected for further research. The in silico prediction revealed that there were complementary sequences between PVT1 and miR424-5p as well as between miR-424-5p and INCENP. Furthermore, a negative correlation trend was found between miR-424-5p and PVT1 based on RT-qPCR, whereas a positive correlation trend was found between PVT1 and INCENP based on data from TCGA. Also, INCENP small interfering RNA (siRNA) could significantly inhibit cell proliferation and viability. Conclusions: We hypothesized that PVT1 could affect the biological function of HCC cells via targeting miR424-5p and regulating INCENP. Focusing on the new insight of the PVT1/miR-424-5p/INCENP axis, this study provides a novel perspective for HCC therapeutic strategies. (C) 2018 The Author(s) Published by S. Karger AG, Basel

A Preliminary Investigation Of Pvt1 On The Effect And Mechanisms Of Hepatocellular Carcinoma: Evidence From Clinical Data, A Meta-Analysis Of 840 Cases, And In Vivo Validation

Long noncoding RNA PVT1 promotes breast cancer proliferation and metastasis by binding miR-128-3p and UPF1

Microarray‑based Bioinformatics Analysis of the Prospective Target Gene Network of Key Mirnas Influenced by Long Non‑coding RNA PVT1 in HCC.

Comprehensive Analysis of Long Non-Coding RNA PVT1 Gene Interaction Regulatory Network in Hepatocellular Carcinoma Using Gene Microarray and Bioinformatics.

LncRNA PVT1 influences breast cancer cells glycolysis through sponging miR-145-5p

Knockdown of long non-coding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p.

Prognostic Significance of LncRNA PVT1 and Its Potential Target Gene Network in Human Cancers: a Comprehensive Inquiry Based Upon 21 Cancer Types and 9972 Cases.

Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer

Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer

Long Noncoding RNA PVT1 Indicates a Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation Through Epigenetically Regulating P15 and P16

Long Non-Coding RNA PVT1 is Associated with Tumor Progression and Predicts Recurrence in Hepatocellular Carcinoma Patients.

Correction For: LncRNA PVT1 Accelerates Malignant Phenotypes of Bladder Cancer Cells by Modulating Mir-194-5p/bclaf1 Axis As a Cerna

Lncrna PVT1 Identified As an Independent Biomarker for Prognosis Surveillance of Solid Tumors Based on Transcriptome Data and Meta-Analysis

LncRNA PVT1: a Novel Therapeutic Target for Cancers.

Positive feedback regulation of lncRNA PVT1 and HIF2 contributes to clear cell renal cell carcinoma tumorigenesis and metastasis

Effect of Long Non-Coding RNA PVT1 on Cell Proliferation and Migration in Melanoma

Positive feedback regulation of lncRNA PVT1 and HIF2α contributes to clear cell renal cell carcinoma tumorigenesis and metastasis

Regulatory Mechanisms and Clinical Applications of the Long Non-coding RNA PVT1 in Cancer Treatment

Lncrna PVT1 Promotes Tumorigenesis of Colorectal Cancer by Stabilizing Mir-16-5p and Interacting with the VEGFA/VEGFR1/AKT Axis

Silencing of lncRNA PVT1 by miR-214 inhibits the oncogenic GDF15 signaling and suppresses hepatocarcinogenesis

The Circular RNA PVT1/miR-203/HOXD3 Pathway Promotes the Progression of Human Hepatocellular Carcinoma